The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.
Recall -- Firm Press Release
FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company.
Finemost Corporation DBA Qualiherb Issues Voluntary Recall of Specific
Lots of the Dietary Supplements containing Ephedrine Alkaloids.
FOR IMMEDIATE RELEASE - July 28, 2011 - Finemost Corporation dba Qualiherb, 13839 Bentley Place, Cerritos, CA 90703 announced today that it is conducting a voluntary nationwide recall of the company’s dietary supplements sold under the brand name Qualiherb specific to the following Lot Numbers:
|Item No.||Products||Mfg. No.|
|20217||Shi Shen Tang||Mahuang & Cimicifuga Combination||CP10217|
|20802||Ding Chuan Tang||Mahuang & Ginkgo Combination||2008-12|
|21022||Shen Mi Tang||Mahuang & Magnolia Combination||CP11022|
|22101||Xu Ming Tang||Mahuang & Ginseng Combination||P122101|
Qualiherb is conducting a voluntary recall after being notified by representatives of the US Food and Drug Administration (FDA) that lab analysis by FDA of the Shi ShenTang, Shen Mi Tang, and Xu Ming Tang samples found the products contain the presence of ephedrine alkaloids.
FDA has concluded that dietary supplements containing ephedrine alkaloids pose a risk of serious adverse events including heart attack, stroke, and death and that these risks are unreasonable in light of any benefits that may result from the use of these products under their labeled conditions of use or under ordinary conditions of use if the labeling is silent.
Qualiherb advises any customers in possession of the above products with matching lot numbers return any unused products to the company directly for a full refund. Customers can call Quality Control at 1- 800-533-5907 Monday thru Friday 8:30 to 5pm Pacific Standard time for instructions on the return and refund process. Any adverse reactions experienced with the use of this product, and/or quality problems should also be reported to the FDA’s MedWatch Program by:
Regular Mail: use postage-paid FDA form 3500 available at:
Mail to: MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787
This recall is being conducted with the knowledge of the U.S. Food and Drug administration.
Recalled Product Photos Are Also Available on FDA's Flickr Photostream.